Reaktion #2354759

ord-f0d568c804a8442eb661f52e3fe9ee29

Reaktionsgleichung

NC(=O)c1cc(-c2ccccc2)cc2c(C3CCNCC3)c[nH]c12
5-phenyl-3-(4-piperidinyl)-1H-indole-7-carboxamide
Cn1cnc(S(=O)(=O)Cl)c1
1-methyl-1H-imidazole-4-sulfonyl chloride
CCN(CC)CC
triethylamine
CCN(CC)CC
TEA
Cn1cnc(S(=O)(=O)N2CCC(c3c[nH]c4c(C(N)=O)cc(-c5ccccc5)cc34)CC2)c1
title compound
Ausbeute 40.4%
Cn1cnc(S(=O)(=O)N2CCC(c3c[nH]c4c(C(N)=O)cc(-c5ccccc5)cc34)CC2)c1
3-{1-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide
Ausbeute 40.4%

Lösungsmittel

Reaktionsbedingungen

Temperatur
0°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeThen the reaction mixture was partitioned between methylene chloride and water
  2. 2
    Extraktionthe aqueous layer was extracted with methylene chloride (25 mL×2)
  3. 3
    Trocknenwas dried with Mg2SO4
  4. 4
    Einengenconcentrated
  5. 5
    Sonstigepurified by Gilson HPLC (reverse phase, eluting with CH3CN/Water, 0.1% TFA, 10/90, v/v, over 15 min)

Vorschrift

To 5-phenyl-3-(4-piperidinyl)-1H-indole-7-carboxamide (40 mg, 0.12 mmol) in methylene chloride (5 mL) at 0° C., 1-methyl-1H-imidazole-4-sulfonyl chloride (27.1 mg, 0.14 mmol) and triethylamine (0.07 mL, 0.50 mmol) were added. The reaction mixture was stirred at 0° C. for 30 min. Then the reaction mixture was partitioned between methylene chloride and water, the aqueous layer was extracted with methylene chloride (25 mL×2) and combined organic phase was dried with Mg2SO4 and concentrated by reduce pressure, and purified by Gilson HPLC (reverse phase, eluting with CH3CN/Water, 0.1% TFA, 10/90, v/v, over 15 min) to give the title compound (22.5 mg, 39%).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07858796B2uspto-grants-2010_12